BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12877935)

  • 41. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J; Bochenski M
    Eur J Pharmacol; 2008 Nov; 598(1-3):57-63. PubMed ID: 18838071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.
    Klodzinska A; Tatarczyńska E; Chojnacka-Wójcik E; Nowak G; Cosford ND; Pilc A
    Neuropharmacology; 2004 Sep; 47(3):342-50. PubMed ID: 15275823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy.
    Nickols HH; Yuh JP; Gregory KJ; Morrison RD; Bates BS; Stauffer SR; Emmitte KA; Bubser M; Peng W; Nedelcovych MT; Thompson A; Lv X; Xiang Z; Daniels JS; Niswender CM; Lindsley CW; Jones CK; Conn PJ
    J Pharmacol Exp Ther; 2016 Jan; 356(1):123-36. PubMed ID: 26503377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist.
    Tatarczyńska E; Klodzińska A; Chojnacka-Wójcik E; Palucha A; Gasparini F; Kuhn R; Pilc A
    Br J Pharmacol; 2001 Apr; 132(7):1423-30. PubMed ID: 11264235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies.
    Zhu A; Wang X; Yu M; Wang JQ; Brownell AL
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1623-31. PubMed ID: 17299451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.
    Maemoto T; Finlayson K; Olverman HJ; Akahane A; Horton RW; Butcher SP
    Br J Pharmacol; 1997 Nov; 122(6):1202-8. PubMed ID: 9401787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.
    Belozertseva IV; Kos T; Popik P; Danysz W; Bespalov AY
    Eur Neuropsychopharmacol; 2007 Feb; 17(3):172-9. PubMed ID: 16630709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the binding pockets of two chemically unrelated allosteric antagonists of the mGlu5 receptor and identification of crucial residues involved in the inverse agonism of MPEP.
    Malherbe P; Kratochwil N; Mühlemann A; Zenner MT; Fischer C; Stahl M; Gerber PR; Jaeschke G; Porter RH
    J Neurochem; 2006 Jul; 98(2):601-15. PubMed ID: 16805850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
    Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
    J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physical and crystallographic characterisation of the mGlu5 antagonist MTEP and its monohydrochloride.
    McIldowie MJ; Gandy MN; Skelton BW; Brotchie JM; Koutsantonis GA; Spackman MA; Piggott MJ
    J Pharm Sci; 2010 Jan; 99(1):234-45. PubMed ID: 19499574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced stress-induced hyperthermia in mGluR5 knockout mice.
    Brodkin J; Bradbury M; Busse C; Warren N; Bristow LJ; Varney MA
    Eur J Neurosci; 2002 Dec; 16(11):2241-4. PubMed ID: 12473093
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the development of morphine-induced rewarding effect in mice.
    Aoki T; Narita M; Shibasaki M; Suzuki T
    Eur J Neurosci; 2004 Sep; 20(6):1633-8. PubMed ID: 15355330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis.
    Fazio F; Notartomaso S; Aronica E; Storto M; Battaglia G; Vieira E; Gatti S; Bruno V; Biagioni F; Gradini R; Nicoletti F; Di Marco R
    Neuropharmacology; 2008 Sep; 55(4):491-9. PubMed ID: 18619983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat.
    van der Kam EL; De Vry J; Tzschentke TM
    Eur J Pharmacol; 2009 Apr; 607(1-3):114-20. PubMed ID: 19326478
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracellular cysteine (Cys)/cystine (CySS) redox regulates metabotropic glutamate receptor 5 activity.
    Zhu JW; Yuan JF; Yang HM; Wang ST; Zhang CG; Sun LL; Yang H; Zhang H
    Biochimie; 2012 Mar; 94(3):617-27. PubMed ID: 21964032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine.
    Montana MC; Cavallone LF; Stubbert KK; Stefanescu AD; Kharasch ED; Gereau RW
    J Pharmacol Exp Ther; 2009 Sep; 330(3):834-43. PubMed ID: 19515968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro metabolic studies on the selective metabotropic glutamate receptor sub-type 5 (mGluR5) antagonist 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl]-pyridine (MTEP).
    Green MD; Yang X; Cramer M; King CD
    Neurosci Lett; 2006 Jan; 391(3):91-5. PubMed ID: 16153770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. mGlu5 and adenosine A2A receptor interactions regulate the conditioned effects of cocaine.
    Brown RM; Duncan JR; Stagnitti MR; Ledent C; Lawrence AJ
    Int J Neuropsychopharmacol; 2012 Aug; 15(7):995-1001. PubMed ID: 21816123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism.
    Cowen MS; Krstew E; Lawrence AJ
    Psychopharmacology (Berl); 2007 Jan; 190(1):21-9. PubMed ID: 17096086
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.